Neuro-oncology clinical trials: Promise and pitfalls

被引：5
|
作者：
Gilbert, MR [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA
来源：
ANNALS OF ONCOLOGY | 2001年 / 12卷 / 02期
关键词：
D O I：
10.1093/oxfordjournals.annonc.a000239
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：149 / 150
页数：2
相关论文
共 50 条
  • [41] The promise and pitfalls of clinical trials overseas
    Normile, Dennis
    SCIENCE, 2008, 322 (5899) : 214 - 216
  • [42] Clinical Relevance of Steroid Use in Neuro-Oncology
    K. Ina Ly
    Patrick Y. Wen
    Current Neurology and Neuroscience Reports, 2017, 17
  • [43] Scientific and Clinical Challenges within Neuro-Oncology
    Barbaro, Marissa
    Fine, Howard A.
    Magge, Rajiv S.
    WORLD NEUROSURGERY, 2021, 151 : 402 - 410
  • [44] Neuro-oncology: clinical and molecular predictive factors
    Vecht, Charles J.
    LANCET NEUROLOGY, 2009, 8 (01): : 17 - 19
  • [45] Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials
    Reardon, David A.
    Okada, Hideho
    JOURNAL OF NEURO-ONCOLOGY, 2015, 123 (03) : 339 - 346
  • [46] Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials
    Ellingson, Benjamin M.
    Brown, Matthew S.
    Boxerman, Jerrold L.
    Gerstner, Elizabeth R.
    Kaufmann, Timothy J.
    Cole, Patricia E.
    Bacha, Jeffrey A.
    Leung, David
    Barone, Amy
    Colman, Howard
    van den Bent, Martin J.
    Wen, Patrick Y.
    Yung, W. K. Alfred
    Cloughesy, Timothy F.
    Goldin, Jonathan G.
    NEURO-ONCOLOGY, 2021, 23 (02) : 189 - 198
  • [47] Novel Clinical Trial Designs in Neuro-Oncology
    Anurag Saraf
    Lorenzo Trippa
    Rifaquat Rahman
    Neurotherapeutics, 2022, 19 : 1844 - 1854
  • [48] Roadmap for the clinical integration of radiomics in neuro-oncology
    Hu, Leland S.
    Swanson, Kristin R.
    NEURO-ONCOLOGY, 2020, 22 (06) : 743 - 745
  • [49] Clinical Relevance of Steroid Use in Neuro-Oncology
    Ly, K. Ina
    Wen, Patrick Y.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (01)
  • [50] PROGRESSION-FREE SURVIVAL: AN IMPORTANT END POINT IN NEURO-ONCOLOGY CLINICAL TRIALS
    Prados, Michael
    NEURO-ONCOLOGY, 2009, 11 (06) : 891 - 891
12345